LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$29.94 MCurrent assets$488.30 MLiabilities$220.21 MAssets$640.55 MNon-current liabilities$190.27 MEquity$420.34 MGross equity(calculated)$442.42 MNon-current assets$152.25 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSShort-term marketable securitiesInventory and other deferred costsAccounts receivable, net of allowances of $1,327 at June 30, 2026 and $1,400 at December 31, 2025Cash and cash equivalentsPrepaid expenses and other current assetsGoodwillOther intangibles, netProperty and equipment, netRight-of-use leased assetsOther assetsDeferred tax assetsAccrued expensesLease liabilities - short-termAccounts payableAcquisition-related obligationsConvertible senior notes, netLease liabilities - long-termDeferred tax liabilitiesOther long-term liabilitiesAdditional paid-in capitalRetained earningsCommon stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectivelyAccumulated other comprehensive lossAccrued expensesAccrued expenses$22.88 MCurrent liabilitiesCurrent liabilities$29.94 MCurrent assetsCurrent assets$488.30 MLease liabilities - short-termLease liabilities - short-term$3.44 MAccounts payableAccounts payable$3.24 MShort-term marketable securitiesShort-term marketable securities$349.62 MLiabilitiesLiabilities$220.21 MAcquisition-related obligationsAcquisition-related obligations$380.00 KAssetsAssets$640.55 MNon-current liabilitiesNon-current liabilities$190.27 MInventory and other deferred costsInventory and other deferred costs$70.50 MConvertible senior notes, netConvertible senior notes, net$169.09 MAccounts receivable, net of allowances of $1,327 at June 30, 2026 and $1,400 at December 31, 2025Accounts receivable, net$35.68 MLease liabilities - long-termLease liabilities - long-term$17.72 MCash and cash equivalentsCash and cash equivalents$26.63 MEquityEquity$420.34 MDeferred tax liabilitiesDeferred tax liabilities$2.00 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$5.87 MOther long-term liabilitiesOther long-term liabilities$1.46 MGross equity (calculated)Gross equity(calculated)$442.42 MGoodwillGoodwill$65.95 MNon-current assetsNon-current assets$152.25 MOther intangibles, netOther intangibles, net$30.54 MAdditional paid-in capitalAdditional paid-in capital$236.16 MProperty and equipment, netProperty and equipment, net$29.59 MRight-of-use leased assetsRight-of-use leased assets$20.00 MRetained earningsRetained earnings$206.02 MOther assetsOther assets$5.44 MDeferred tax assetsDeferred tax assets$734.00 KCommon stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectivelyCommon stock$245.00 KTreasury stock, at cost; 1,629,267 and 1,624,297 shares, respectivelyTreasury stock−$17.92 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$4.17 M
Chart details

LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
640,549,000 US dollars
Current assets
488,297,000 US dollars
Non-current assets
152,252,000 US dollars
Liabilities
220,207,000 US dollars
Current liabilities
29,935,000 US dollars
Non-current liabilities
190,272,000 US dollars
Equity
420,342,000 US dollars
Short-term marketable securities
349,615,000 US dollars
Inventory and other deferred costs
70,503,000 US dollars
Accounts receivable, net of allowances of $1,327 at June 30, 2026 and $1,400 at December 31, 2025
35,682,000 US dollars
Cash and cash equivalents
26,625,000 US dollars
Prepaid expenses and other current assets
5,872,000 US dollars
Goodwill
65,945,000 US dollars
Other intangibles, net
30,544,000 US dollars
Property and equipment, net
29,591,000 US dollars
Right-of-use leased assets
19,998,000 US dollars
Other assets
5,440,000 US dollars
Deferred tax assets
734,000 US dollars
Accrued expenses
22,880,000 US dollars
Lease liabilities - short-term
3,439,000 US dollars
Accounts payable
3,236,000 US dollars
Acquisition-related obligations
380,000 US dollars
Convertible senior notes, net
169,091,000 US dollars
Lease liabilities - long-term
17,724,000 US dollars
Deferred tax liabilities
1,998,000 US dollars
Other long-term liabilities
1,459,000 US dollars
Additional paid-in capital
236,161,000 US dollars
Retained earnings
206,017,000 US dollars
Common stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectively
245,000 US dollars
Preferred stock, $0.01 par value; 3,000,000 shares authorized; none issued and outstanding
0 US dollars
Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectively
negative 17,916,000 US dollars
Accumulated other comprehensive loss
negative 4,165,000 US dollars
Gross equity (calculated)
442,423,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!